The vaccine uses lipid nanoparticles (LNPs) to encapsulate the mRNA. These LNPs protect the mRNA from degradation and facilitate its entry into human cells. Once inside the cells, the mRNA instructs them to produce the spike protein found on the surface of the coronavirus. The immune system then recognizes this protein as foreign and mounts an immune response, preparing the body to fight the actual virus.
